Pharma Companies

“This is also why SCGBT quickly become one of the most widely used single cell foundation model in pharma companies.”

“Pharma companies are rationally incredibly averse to switching their process because they've already, you know, they make tons of investments or acquisitions across all these different sort of binary bets. You get one that works, you don't want to have to go d…”

“Part of the issue is, in that process, they have to try and make it, you know, somewhat simple, so that when it goes into the real world, into the clinic, it's easy for the mass population to follow that dosing guidance, and that's okay with certain drugs that…”

“Food companies make foods that make you more addicted to the foods that you're eating. Pharma companies come in and they say, oh, cool, we have this thing that's going to help you mask the system, but, or mask the symptom, but what's going to happen is, is tha…”

“The USD nutrition guidelines committee, which basically approves and recommends various foods. 95% of it is funded by 95% of the panelists are directly funded by food companies or pharma companies.”

“The interesting thing is, you know, we do work with some kind of conventional hospital systems, but the larger, like our largest customers are, like I said, pharma companies and insurers that don't directly employ healthcare providers, but they have networks o…”

“I think most acquisitions that you see in, in biotech are late stage to marketed stage companies, so they are, I think pharma companies are still very conservative in terms of making big bets on early stage platforms for acquisition.”

“So, so, you know, it's typical to You know, see pharma companies wait for proof of concept, you know, phase IIa data that shows safety and some efficacy before doubling down.”

“The payers probably have more and better real-world data than the pharma companies do, and one of the reasons that the pharma companies will eventually, in my opinion, have to do data sharing, as Andrew suggests, is that the payers are going to aggregate their…”

“Pharma companies are swimming in targets, right? The problem they're trying to solve for is how do I fill in my pipeline?”

“Whatever the technology is, they got the cool technology, they think this will change drug design, and so then they go to pharma and they try to sell it. And pharma's not convinced yet. Ah, it's like my kids with new foods, and they don't want to try it until …”

“And I think we're seeing this more and more, where pharma companies will start to view themselves more as data generating companies. And data science companies as machine learning gets in,”

“The pharma companies are desperate for buying in innovation, and so they're really looking for companies to get to that initial proof of concept in a human, in human studies. So that, that's really where a lot of their innovation is coming from, is biotechs th…”